WHO ICTRP trial
oxytocin vs oxytocin & methylergometrine in controlling intrapartum cesarean…
CTRI/2023/07/055548 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2023/07/055548 |
|---|---|
| Public title | oxytocin vs oxytocin & methylergometrine in controlling intrapartum cesarean section |
| Scientific title | A Randomised Control Trial comparing effectiveness of oxytocin with methylergometrine with Oxytocin alone in patients undergoing intrapartum cesarean section - nil |
| Primary sponsor | AIIMS Jodhpur |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2/ Phase 3 |
| Countries | India |
| Interventions | Intervention1: Methylergometrine (0.2 mg IM )with oxytocin (5U iv ) in intervention group for 24 hrs post delivery: Methylergometrine ( intramuscularly 0.2 mg )with oxytocin (5 IU intravenously slow bolus) will be given in intervention… |
| Registration date | Jul 24, 2023 |
| Target size | 190 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: